Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Minor website revision updates were made: Revision v3.4.2 was added and Revision v3.4.1 was removed. No user-facing content or study data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T04:21:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed the previous notices (Revision: v3.4.0) related to government funding and operating status.
    Difference
    0.1%
    Check dated 2026-02-10T01:11:33.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top with links to cc.nih.gov and opm.gov, and added a 2025 Arthritis Research & Therapy article citation by Gossec et al. on risankizumab in PsA while removing the online-ahead-of-print note for that citation.
    Difference
    0.1%
    Check dated 2026-02-02T21:12:41.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a glossary display toggle; updated labels including 'Last Update Submitted that Met QC Criteria' capitalization and changed the No FEAR Act data phrasing, with the revision updated to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-26T19:37:39.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T14:45:31.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Expanded the Locations section with numerous new sites across multiple regions and removed several existing locations.
    Difference
    3%
    Check dated 2025-12-21T23:23:30.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.